Single nucleotide and copy number polymorphisms of the SULT1A1 gene in a South African Tswana population group
Keywords:
Tswana, SULT1A1, SULT1A1*1, SULT1A1*2, polymorphism, copy number, allele frequency distribution, sulphonation, PURE Study
Abstract
Previous studies on gene mapping have firmly established variation in segments of the DNA structure amongst different population groups. SULT1A1 is one of four SULT1A genes that maps to the short arm of chromosome 16, and this area has been shown to contain many repetitive sequences and to be highly duplicated. Using the polymerase chain reaction (PCR)-based restriction fragment length polymorphism method, we set out to determine the SULT1A1 genotype and allele frequency distributions in the largest sample studied to date: a homogeneous South African Tswana population of 1867 individuals from the Prospective Urban and Rural Epidemiological (PURE) study, and found the SULT1A1*1 and SULT1A1*2 alleles present at a frequency of 0.68 and 0.32, respectively. This finding corresponded with those obtained for the Black, Caucasian, and mixed-race South African groups reported in previous studies. Next, using a quantitative multiplex PCR method to estimate the SULT1A1 gene number of copies in 459 subjects of our population, we discovered between one and five copies: 0.65% of the subjects had a single copy (allele deletion) and 60.14% of the subjects had three or more copies. Our findings correspond with an earlier study on a small African–American group, but differ from those based on two Caucasian groups. Whereas the genotype distribution was comparable to the Caucasian groups, there was a significant difference in the number of copies, which indicated a genetic link between Tswana and African–American populations despite differences in cultural lifestyle associated with their geographical location.References
1.Visser TJ, Kaptein E, Glatt H, Bartsch I, Hagen M, Coughtrie MWH.Characterization of thyroid hormone sulfotransferases. Chem-Biol Interact. 1998;109:279–291. http://dx.doi.org/10.1016/S0009-2797(97)00139-7
2.Hempel N, Gamage N, Martin JL, McManus ME. Human cytosolic sulfotransferase SULT1A1. Int J Biochem Cell Biol. 2007;39:685–689. http://dx.doi.org/10.1016/j.biocel.2006.10.002
3.Negishi M, Pedersen LG, Petrotchenko E, et al. Structure and function of sulfotransferases. Arch Biochem Biophys. 2001;390:149–157. http://dx.doi.org/10.1006/abbi.2001.2368, PMid:11396917
4.Rath VL, Verdugo D, Hemmerich S. Sulfotransferase structural biology and inhibitor discovery. Drug Discov Today. 2004;9:1003–1011. http://dx.doi.org/10.1016/S1359-6446(04)03273-8
5.Taskinen J, Ethell B, Lautala P, Hood AM, Burchell B, Coughtrie MWH. Conjugation of catechols by recombinant human sulfotransferases, UDP glucuronosyltransferases, and soluble catechol O-methyltransferase: Structure-conjugation relationships and predictive models. Drug Met Dispos. 2003;31:1187–1197. http://dx.doi.org/10.1124/dmd.31.9.1187, PMid:12920175
6.Coughtrie MWH. Sulfation through the looking glass – recent advances in sulfotransferase research for the curious. Pharmacogenomics. 2002;2:297–308. http://dx.doi.org/10.1038/sj.tpj.6500117, PMid:12439736
7.Coughtrie WHC, Gilissen RAHJ, Shek B, et al. Phenol sulphotransferase SULT1A1 polymorphism: Molecular diagnosis and allele frequencies in Caucasian and African populations. Biochem J. 1999;337:45–49. http://dx.doi.org/10.1042/0264-6021:3370045, PMid:9854023, PMCid:1219934
8.Weinshilboum R. Phenol sulfotransferase inheritance. Cell Mol Neurobiol. 1988;8(1):27–34. http://dx.doi.org/10.1007/BF00712908, PMid:3042142
9.Ozawa S, Shimizu M, Katoh T, et al. Sulfating-activity and stability of cDNA expressed allozymes of human phenol sulfotransferase, ST1A3*1 ((213)Arg) and ST1A3*2 ((213)His), both of which exist in Japanese as well as Caucasians. Biochemistry. 1999;126:271–277.
10.Sun XF, Ahmadi A, Arbman G, Wallin A, Asklid D, Zhang H. Polymorphisms in sulfotransferase 1A1 and glutathione S-transferase P1 genes in relation tocolorectal cancer risk and patients’ survival. World J Gastroenterol. 2005;11:6875–6879. PMid:16425401
11.Nowell S, Ratnasinghe DL, Ambrosone CB, et al. Association of SULT1A1 phenotype and genotype with prostate cancer risk in African–Americans and Caucasians. Cancer Epidem Biomar. 2004:13:270–276. http://dx.doi.org/10.1158/1055-9965.EPI-03-0047
12.Glatt HR. Bioactivation of mutagens via sulfation. FASEB J. 1997;11:314–321. PMid:9141497
13.Nowell S, Sweeney C, Winters M, et al. Association between sulfotransferase 1A1 genotype and survival of breast cancer patients receiving tamoxifen therapy. Nat Cancer Instit. 2002;94:1635–1640.
14.Buckley PG, Mantripragada KK, Piotrowski A, De Stahl TD, Dumanski JP. Copy-number polymorphisms: Mining the tip of an iceberg. Trends Genet. 2005;21:315–317. http://dx.doi.org/10.1016/j.tig.2005.04.007, PMid:15922827
15.McCarroll SA, Hadnott TN, Perry GH, et al. Common deletion polymorphism in human genome. Nature Genet. 2006;38:86–92. http://dx.doi.org/10.1038/ng1696
16.Redon R, Ishikawa S, Fitch KR, et al. Global variation in copy number in the human genome. Nature. 2006;444:444–454. http://dx.doi.org/10.1038/nature05329, PMid:17122850, PMCid:2669898
17.Fredman D, White SJ, Potter S, Eichler EE, Den Dunnen JT, Brookes AJ. Complex SNP-related sequence variation in segmental genome duplications. Nature Genet. 2004;36(8):861–866. http://dx.doi.org/10.1038/ng1401, PMid:15247918
18.Feuk L, Marshall CR, Wintle RF, Scherer SW. Structural variants: changing the landscape of chromosomes and design of disease studies. Hum Mol Gen. 2006;15(1):R57–R66. http://dx.doi.org/10.1093/hmg/ddl057, PMid:16651370
19.Sebat J, Lakshmi B, Troge J, et al. Large-scale copy number polymorphism in the human genome. Science. 2004;305:525–527. http://dx.doi.org/10.1126/science.1098918, PMid:15273396
20.Hebbring SJ, Adjei AA, Baer JL, et al. Human SULT1A1 gene: Copy number differences and functional implications. Hum Mol Gen. 2007;16:463–470. http://dx.doi.org/10.1093/hmg/ddl468, PMid:17189289
21.Dandara C, Li DP, Walther G, Parker MI. Gene-environment interaction: The role of SULT1A1 and CYP3A5 polymorphisms as risk modifiers for squamous cell carcinoma of the oesophagus. Carcinogenesis. 2006;27(4):791–797. http://dx.doi.org/10.1093/carcin/bgi257, PMid:16272171
22.Schuster SC, Miller W, Ratan A, et al. Complete Khoisan and Bantu genomes from southern Africa. Nature Lett. 2010;463:943–947. http://dx.doi.org/10.1038/nature08795, PMid:20164927
23.Teo K, Chow CK, Vaz M, Rangarajan S, Yusuf S. The Prospective Urban Rural Epidemiology (PURE) study: Examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries. Am Heart J. 2009;158:1–8. http://dx.doi.org/10.1016/j.ahj.2009.04.019, PMid:19540385
24.Population genetics. In: Snyder LA, Freifelder D, Hartl DL, editors. General genetics. Boston, MA: Jones and Bartlett, 1985; 494–528.
25.Goodman LA. On simultaneous confidence intervals for multinomial proportions. Technometrics. 1965;7:247–254. http://dx.doi org/10.2307/ 1266673
26.Statistical Package for the Social Sciences (SPSS). Version 18. Armonk, NY: IBM; 2009.
27.Statistica. Version 9. Tulsa, OK: StatSoft; 2009.
28.R. Version 2.12.0. Vienna: R Development Core Team; 2010.
29.Windows Excel 7. Redmond, WA: Microsoft Corporation; 2009.
30.Hempel N, Masahiko N, McManus ME. Human SULT1A genes: Cloning and activity assays of the SULT1A promoters. Methods Enzymol. 2005;400:147–165. http://dx.doi.org/10.1016/S0076-6879(05)00009-1
31.Gjerde J, Hauglid M, Breilid H, et al. Effects of CYP2D6 and SULT1A1 genotypes including SULT1A1 gene copy number on tamoxifen metabolism. Ann Oncol. 2007;19(1):56-61. http://dx.doi.org/10.1093/annonc/mdm434, PMid:17947222
32.Han DF, Zhou X, Hu MB, et al. Sulfotransferase 1A1 (SULT1A1) polymorphism and breast cancer risk in Chinese women. Toxicol Lett. 2004;150:167–177. http://dx.doi.org/10.1016/j.toxlet.2004.01.012, PMid:15093672
33.Ohtake E, Kakihara F, Matsumoto N, et al. Frequency distribution of phenol sulfotransferase 1A1 activity in platelet cells from healthy Japanese subjects. Eur J Pharm Sci. 2006;28:272–277. http://dx.doi.org/10.1016/j.ejps.2006.02.008, PMid:16621480
34.Cann RL, Stoneking M, Wilson AC. Mitochondrial DNA and human evolution. Nature. 1987;325:31–36. http://dx.doi.org/10.1038/325031a0, PMid:3025745
35.Korbel JO, Kim PM, Chen X, et al. The current excitement about copy-number variation: How it relates to gene duplications and protein families. Curr Opin Struct Biol. 2008;18:1–9. http://dx.doi.org/10.1016/j.sbi.2008.02.005, PMid:18511261, PMCid:2577873
36.McCarroll SA, Altshuler DM. Copy-number variation and association studies of human disease. Nat Genet Suppl. 2007;39:S37-S42.
37.Freeman JL, Perry GH, Feuk L, et al. Copy number variation: New insights in genome diversity. Genome Res. 2006;16:949-961.
38.Desta Z, Zhao X, Shin JG, Flockhart DA. Clinical significance of the cytochrome P450 2C19 genetic polymorphism. Clin Pharmacokinet. 2002;41:913-958.
39.Devi SS, Vinayagamoorthy N, Agrawal M, et al. Distribution of detoxifying genes polymorphism in Maharastrian population of central India.Chemosphere. 2008;70:1835-1839.
40.Dalhoff K, Buus JK, Enghusen PH. Cancer and molecular biomarkers of phase 2. Methods Enzymol. 2005;400:618–627. http://dx.doi.org/10.1016/S00766879(05)00035-2
41.Raftogianis RB, Wood TC, Otterness DM, et al. Phenol sulfotransferase pharmacogenetics in humans: Association of common SULT1A1 alleles with TS PST phenotype. Biochem Biophys Res Commun. 1997;239:298–304. http://dx.doi.org/10.1006/bbrc.1997.7466, PMid:9345314
2.Hempel N, Gamage N, Martin JL, McManus ME. Human cytosolic sulfotransferase SULT1A1. Int J Biochem Cell Biol. 2007;39:685–689. http://dx.doi.org/10.1016/j.biocel.2006.10.002
3.Negishi M, Pedersen LG, Petrotchenko E, et al. Structure and function of sulfotransferases. Arch Biochem Biophys. 2001;390:149–157. http://dx.doi.org/10.1006/abbi.2001.2368, PMid:11396917
4.Rath VL, Verdugo D, Hemmerich S. Sulfotransferase structural biology and inhibitor discovery. Drug Discov Today. 2004;9:1003–1011. http://dx.doi.org/10.1016/S1359-6446(04)03273-8
5.Taskinen J, Ethell B, Lautala P, Hood AM, Burchell B, Coughtrie MWH. Conjugation of catechols by recombinant human sulfotransferases, UDP glucuronosyltransferases, and soluble catechol O-methyltransferase: Structure-conjugation relationships and predictive models. Drug Met Dispos. 2003;31:1187–1197. http://dx.doi.org/10.1124/dmd.31.9.1187, PMid:12920175
6.Coughtrie MWH. Sulfation through the looking glass – recent advances in sulfotransferase research for the curious. Pharmacogenomics. 2002;2:297–308. http://dx.doi.org/10.1038/sj.tpj.6500117, PMid:12439736
7.Coughtrie WHC, Gilissen RAHJ, Shek B, et al. Phenol sulphotransferase SULT1A1 polymorphism: Molecular diagnosis and allele frequencies in Caucasian and African populations. Biochem J. 1999;337:45–49. http://dx.doi.org/10.1042/0264-6021:3370045, PMid:9854023, PMCid:1219934
8.Weinshilboum R. Phenol sulfotransferase inheritance. Cell Mol Neurobiol. 1988;8(1):27–34. http://dx.doi.org/10.1007/BF00712908, PMid:3042142
9.Ozawa S, Shimizu M, Katoh T, et al. Sulfating-activity and stability of cDNA expressed allozymes of human phenol sulfotransferase, ST1A3*1 ((213)Arg) and ST1A3*2 ((213)His), both of which exist in Japanese as well as Caucasians. Biochemistry. 1999;126:271–277.
10.Sun XF, Ahmadi A, Arbman G, Wallin A, Asklid D, Zhang H. Polymorphisms in sulfotransferase 1A1 and glutathione S-transferase P1 genes in relation tocolorectal cancer risk and patients’ survival. World J Gastroenterol. 2005;11:6875–6879. PMid:16425401
11.Nowell S, Ratnasinghe DL, Ambrosone CB, et al. Association of SULT1A1 phenotype and genotype with prostate cancer risk in African–Americans and Caucasians. Cancer Epidem Biomar. 2004:13:270–276. http://dx.doi.org/10.1158/1055-9965.EPI-03-0047
12.Glatt HR. Bioactivation of mutagens via sulfation. FASEB J. 1997;11:314–321. PMid:9141497
13.Nowell S, Sweeney C, Winters M, et al. Association between sulfotransferase 1A1 genotype and survival of breast cancer patients receiving tamoxifen therapy. Nat Cancer Instit. 2002;94:1635–1640.
14.Buckley PG, Mantripragada KK, Piotrowski A, De Stahl TD, Dumanski JP. Copy-number polymorphisms: Mining the tip of an iceberg. Trends Genet. 2005;21:315–317. http://dx.doi.org/10.1016/j.tig.2005.04.007, PMid:15922827
15.McCarroll SA, Hadnott TN, Perry GH, et al. Common deletion polymorphism in human genome. Nature Genet. 2006;38:86–92. http://dx.doi.org/10.1038/ng1696
16.Redon R, Ishikawa S, Fitch KR, et al. Global variation in copy number in the human genome. Nature. 2006;444:444–454. http://dx.doi.org/10.1038/nature05329, PMid:17122850, PMCid:2669898
17.Fredman D, White SJ, Potter S, Eichler EE, Den Dunnen JT, Brookes AJ. Complex SNP-related sequence variation in segmental genome duplications. Nature Genet. 2004;36(8):861–866. http://dx.doi.org/10.1038/ng1401, PMid:15247918
18.Feuk L, Marshall CR, Wintle RF, Scherer SW. Structural variants: changing the landscape of chromosomes and design of disease studies. Hum Mol Gen. 2006;15(1):R57–R66. http://dx.doi.org/10.1093/hmg/ddl057, PMid:16651370
19.Sebat J, Lakshmi B, Troge J, et al. Large-scale copy number polymorphism in the human genome. Science. 2004;305:525–527. http://dx.doi.org/10.1126/science.1098918, PMid:15273396
20.Hebbring SJ, Adjei AA, Baer JL, et al. Human SULT1A1 gene: Copy number differences and functional implications. Hum Mol Gen. 2007;16:463–470. http://dx.doi.org/10.1093/hmg/ddl468, PMid:17189289
21.Dandara C, Li DP, Walther G, Parker MI. Gene-environment interaction: The role of SULT1A1 and CYP3A5 polymorphisms as risk modifiers for squamous cell carcinoma of the oesophagus. Carcinogenesis. 2006;27(4):791–797. http://dx.doi.org/10.1093/carcin/bgi257, PMid:16272171
22.Schuster SC, Miller W, Ratan A, et al. Complete Khoisan and Bantu genomes from southern Africa. Nature Lett. 2010;463:943–947. http://dx.doi.org/10.1038/nature08795, PMid:20164927
23.Teo K, Chow CK, Vaz M, Rangarajan S, Yusuf S. The Prospective Urban Rural Epidemiology (PURE) study: Examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries. Am Heart J. 2009;158:1–8. http://dx.doi.org/10.1016/j.ahj.2009.04.019, PMid:19540385
24.Population genetics. In: Snyder LA, Freifelder D, Hartl DL, editors. General genetics. Boston, MA: Jones and Bartlett, 1985; 494–528.
25.Goodman LA. On simultaneous confidence intervals for multinomial proportions. Technometrics. 1965;7:247–254. http://dx.doi org/10.2307/ 1266673
26.Statistical Package for the Social Sciences (SPSS). Version 18. Armonk, NY: IBM; 2009.
27.Statistica. Version 9. Tulsa, OK: StatSoft; 2009.
28.R. Version 2.12.0. Vienna: R Development Core Team; 2010.
29.Windows Excel 7. Redmond, WA: Microsoft Corporation; 2009.
30.Hempel N, Masahiko N, McManus ME. Human SULT1A genes: Cloning and activity assays of the SULT1A promoters. Methods Enzymol. 2005;400:147–165. http://dx.doi.org/10.1016/S0076-6879(05)00009-1
31.Gjerde J, Hauglid M, Breilid H, et al. Effects of CYP2D6 and SULT1A1 genotypes including SULT1A1 gene copy number on tamoxifen metabolism. Ann Oncol. 2007;19(1):56-61. http://dx.doi.org/10.1093/annonc/mdm434, PMid:17947222
32.Han DF, Zhou X, Hu MB, et al. Sulfotransferase 1A1 (SULT1A1) polymorphism and breast cancer risk in Chinese women. Toxicol Lett. 2004;150:167–177. http://dx.doi.org/10.1016/j.toxlet.2004.01.012, PMid:15093672
33.Ohtake E, Kakihara F, Matsumoto N, et al. Frequency distribution of phenol sulfotransferase 1A1 activity in platelet cells from healthy Japanese subjects. Eur J Pharm Sci. 2006;28:272–277. http://dx.doi.org/10.1016/j.ejps.2006.02.008, PMid:16621480
34.Cann RL, Stoneking M, Wilson AC. Mitochondrial DNA and human evolution. Nature. 1987;325:31–36. http://dx.doi.org/10.1038/325031a0, PMid:3025745
35.Korbel JO, Kim PM, Chen X, et al. The current excitement about copy-number variation: How it relates to gene duplications and protein families. Curr Opin Struct Biol. 2008;18:1–9. http://dx.doi.org/10.1016/j.sbi.2008.02.005, PMid:18511261, PMCid:2577873
36.McCarroll SA, Altshuler DM. Copy-number variation and association studies of human disease. Nat Genet Suppl. 2007;39:S37-S42.
37.Freeman JL, Perry GH, Feuk L, et al. Copy number variation: New insights in genome diversity. Genome Res. 2006;16:949-961.
38.Desta Z, Zhao X, Shin JG, Flockhart DA. Clinical significance of the cytochrome P450 2C19 genetic polymorphism. Clin Pharmacokinet. 2002;41:913-958.
39.Devi SS, Vinayagamoorthy N, Agrawal M, et al. Distribution of detoxifying genes polymorphism in Maharastrian population of central India.Chemosphere. 2008;70:1835-1839.
40.Dalhoff K, Buus JK, Enghusen PH. Cancer and molecular biomarkers of phase 2. Methods Enzymol. 2005;400:618–627. http://dx.doi.org/10.1016/S00766879(05)00035-2
41.Raftogianis RB, Wood TC, Otterness DM, et al. Phenol sulfotransferase pharmacogenetics in humans: Association of common SULT1A1 alleles with TS PST phenotype. Biochem Biophys Res Commun. 1997;239:298–304. http://dx.doi.org/10.1006/bbrc.1997.7466, PMid:9345314